Aktive Positionen von Wen Jia Li
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Guangdong HEC Biological Pharmacy Co., Ltd.
 Guangdong HEC Biological Pharmacy Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong HEC Biological Pharmacy Co., Ltd. engages in the research, development, production, and sale of medicines and medical equipment. It also engages in the development of stem cell technology, stem cell drugs, and immune cell biotechnology. The company was founded on February 10, 2017 and is headquartered in Dongguan, China. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - | |
Sunshine Lake Pharma Co. Ltd.
 Sunshine Lake Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Shenzhen HEC Industrial Development Co., Ltd., Sunshine Lake Pharma Co. Ltd. is a Chinese company that manufactures and supplies pharmaceutical ingredients and drugs. The company is based in GD. Wen Jia Li has been the CEO of the company since 2021. Sunshine Lake Pharma Co. was acquired by Shenzhen HEC Industrial Development Co., Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. on December 23, 2022 for $330.99 million. | Direktor/Vorstandsmitglied | 22.01.2021 | - |
| Vorstandsvorsitzender | 22.01.2021 | - |
Karriereverlauf von Wen Jia Li
Statistik
International
| China | 3 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Sunshine Lake Pharma Co. Ltd.
Sunshine Lake Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Shenzhen HEC Industrial Development Co., Ltd., Sunshine Lake Pharma Co. Ltd. is a Chinese company that manufactures and supplies pharmaceutical ingredients and drugs. The company is based in GD. Wen Jia Li has been the CEO of the company since 2021. Sunshine Lake Pharma Co. was acquired by Shenzhen HEC Industrial Development Co., Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. on December 23, 2022 for $330.99 million. | Health Technology |
Guangdong HEC Biological Pharmacy Co., Ltd.
Guangdong HEC Biological Pharmacy Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong HEC Biological Pharmacy Co., Ltd. engages in the research, development, production, and sale of medicines and medical equipment. It also engages in the development of stem cell technology, stem cell drugs, and immune cell biotechnology. The company was founded on February 10, 2017 and is headquartered in Dongguan, China. | Health Technology |
- Börse
- Insiders
- Wen Jia Li
- Erfahrung
